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It has been generally accepted that inhibition of apoptosis is important in the development of malignancy. To determine
whether Epstein–Barr virus (EBV) latent membrane protein 1 (LMP1), the virus-coded transforming oncogene product, has
an anti-apoptotic function in non-B-cells, Jurkat T cells were transfected with the LMP1-expression vector pSV2gptMTLM
consisting of the human metallothionein promoter and were selected for mycophonolic acid resistance. LMP1-expressing
clones of Jurkat cells showed resistance to apoptosis induced by serum deprivation. In LMP1-expressing clones, although
the levels of Bcl-2 and Bax were similar to those in the clones of vector transfectants or parental cells, c-Myc expression
was significantly depressed. Down-regulation of c-Myc by LMP1 was confirmed by using LMP1-expressing clones treated
with CdCl2 . Addition of c-myc antisense oligonucleotides to Jurkat cells specifically inhibited apoptosis induced by serum
deprivation at the concentrations which suppressed c-Myc expression. These results suggest that LMP1 expression and
subsequent down-regulation of c-Myc protect Jurkat T cells from apoptosis induced by serum deprivation. The significance
of the anti-apoptotic function of LMP1 in non-B, Jurkat T cells is discussed in relation to the pathogenesis of EBV malignancy.
q 1997 Academic Press
INTRODUCTION malignancy by acting to promote cell survival as well as
cell growth at least in B cells.
Epstein–Barr virus (EBV)-induced B-lymphocyte It has been reported that EBV is associated with sev-
growth transformation is associated with the expression eral malignancies including Burkitt’s lymphoma, naso-
of six nuclear proteins, EBNA-1, -2, -3A, -3B, -3C, and pharingeal carcinoma (NPC), lymphoproliferative disor-
-LP, and three latent membrane proteins, LMP1, LMP2A, ders, a certain type of T-cell lymphoma, and Hodgkin’s
and LMP2B (Kieff, 1989). One of the latently expressed lymphoma (Klein, 1979; Cleary et al., 1986; Lenoir, 1986;
proteins, LMP1, is likely to have an important role in the Young et al., 1989; Chen et al., 1993; Pallesen et al.,
initiation and/or maintenance of the immortalized state. 1993; Khan and Coates, 1994). LMP1 is found in EBV-
The expression of LMP1 in certain EBV-negative Burkitt associated, non-B-cell malignancies, being detected in
lymphoma (BL) cell lines yields some phenotypes similar 40 to 70% of all NPC (Fahraeus et al., 1988; Young et al.,
to those observed in primary B cells upon infection with 1988; Li-Fu et al., 1991) and in more than 40% of Hodg-
EBV. LMP1-positive derivatives of some EBV-negative BL kin’s lymphoma (Pallesen et al., 1993; Khan and Coates,
cell lines express increased levels of the B-cell activation 1994). This finding suggests the LMP1 may play a direct
molecules such as CD23 and CD39 as well as of several role in the neoplastic transformation of non-B-cell in vivo.
cellular adhesion molecules (LFA-1, LFA-3, and ICAM-1) Therefore, it is very important to clarify the function of
and decreased levels of CD10 (Wang et al., 1988, 1990; LMP1 in the non-B-cell type to understand the pathogen-
Rowe et al., 1994). In addition, recent work has shown esis of EBV malignancy. LMP1 is the only virus-encoded
that the expression of LMP1 in B cells results in the protein shown to have the function of a transforming
induction of Bcl-2 oncogene which prevents apoptosis oncogenes in rodent fibroblast lines, such as Rat-1 and
and the expression of Bcl-2 confers a survival function on BALB/3T3 cells (Wang et al., 1985; Balchwal and Sugden,
the cells (Henderson et al., 1991). It has been generally 1988). LMP1 has been demonstrated to block differentia-
accepted that inhibition of apoptosis is important in the tion of the human SCC-12F epithelial cell line (Dowson
development of malignancy. LMP1 therefore has the po- et al., 1990). However, the role of LMP1 against apoptosis
tential to contribute to pathogenesis of EBV-associated induced in non-B-cells has remained to be clarified. In
the present study, the EBV-encoded LMP1 gene was
expressed in Jurkat T cells. LMP1-expressing clones of1 To whom reprint requests should be addressed at Department of
Jurkat cells were resistant to apoptosis induced by serumMicrobiology, Graduate School of Medicine, Kyoto University, Kyoto,
606-01, Japan. Fax: 81-75-753-4446. deprivation. Cellular Bcl-2 and Bax proteins interact to
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preside over the cellular decision between life and death then 100 mg/ml proteinase K for 2 hr at 377. DNA was
purified by phenol/chloroform and analyzed by conven-(Yin et al., 1994). However, the levels of Bcl-2 and Bax
in LMP1-expressing clones were similar to those in the tional electrophoresis on 1.4% agarose gels containing
0.5 mg/ml ethidium bromide at 60 V for 3 hr.clones of vector transfectants or parental cells. In con-
trast, the expression of LMP1 in Jurkat cells causes de-
Immunoblot analysiscreased expression of c-Myc. Antisense oligonucleotides
to c-myc inhibit apoptosis induced in Jurkat cells by Cells were solubilized in gel sample buffer [50 mM
serum deprivation at the concentrations which suppress Tris buffer (pH 6.8), 2% sodium dodecyl sulfate (SDS), 2%
c-Myc expression. These results suggest that LMP1 ex- 2-mercaptoethanol, 10% glycerol, and 0.1% bromophenol
pression and subsequent down-regulation of c-Myc pro- blue], sonicated for 20 sec, and then boiled for 5 min.
tect Jurkat T cells from apoptosis induced by serum depri- Samples containing 0.5 1 106 cells in 20 ml were sepa-
vation. rated by the discontinuous gel electrophoresis technique
of Laemmli with a 5% acrylamide stacking gel and an 8%
MATERIALS AND METHODS acrylamide resolving gel and blotted onto PVDF mem-
branes. Excess protein-binding sites on the blotted mem-Electroporation and isolation of transfected cells
branes were blocked by incubation for 2 hr in 29 mM
Jurkat and Raji cell lines were grown as described Tris-buffered saline, pH 7.5 (TBS), containing 5% dried
before (Kawanishi et al., 1981). A pulse-generating ma- skim milk (TBS-milk). The membranes were then incu-
chine which delivers exponentially decaying pulses over bated at 47 overnight with first antibodies diluted in TBS-
broad range of pulse lengths was used for electropora- milk. The immunoblotted membranes were washed in
tion. Electroporation was performed at a pulse of 1– 2 TBS containing 0.1% Tween 20 before incubating for 2
kV/cm with 150 msec of decay time constant. Cells in the hr with peroxidase-conjugated second antibodies or pro-
phase of logarithmic growth were washed with cold tein A in TBS-milk. After extensive washings in TBS–
PBS –0.3 M mannitol (1:1) twice and incubated at a den- Tween 20, the filters were incubated in ECL detection
sity of 5 1 106 cells/ml with DNA for 10 min followed by reagent (Amersham) and exposed to RP X-Omat film (Ko-
electroporation. After incubation at 377 for 1 hr in 10 vol dak). Monoclonal antibodies against EBV LMP1 (CS 1-4)
of warmed RPMI with 10% FCS, cells were resuspended and Bcl-2 oncoprotein were obtained from Dako Japan
in the same medium at a density of 1 1 106 cells/ml and Co., Ltd. Rabbit polyclonal antibody against Bax and
incubated for 2 days. Cells transfected with monoclonal antibodies against c-Myc were purchased
pSV2gptMTLM or pSV2gpt as a control were cultured in from Santa Cruz Biotechnology, Inc.
medium containing 160 mg/ml of xanthin, 10 mg/ml of
Oligonucleotide preparationhypoxanthine, and 2 mg/ml of mycophenolic acid. After
2 weeks, the cells were plated in 96-well flat-bottomed Oligonucleotides were purchased from Kurabou Bio-
microdilution plates at a density of 5 cells/ml. Alterna- medical Ltd. The last two phosphodiesters at each end
tively, transfected cells were directly plated in 96-well of the oligomer were thioated. The sequences of the
plates at a density of 5 1 103 cells/ml without incubation oligodeoxynucleotides were as follows: antisense to c-
for 2 weeks. myc, 5*-AACGTTGAGGGGCAT-3*; sense to c-Myc, 5*-
ATGCCCCTCAACGTT-3*.
Apoptosis assays
RESULTSAfter washing with serum-free RPMI medium three
times, cells were suspended at a concentration of 3 1 Apoptosis in LMP1-transfected Jurkat cell
105 cells/ml and incubated at 377. At the indicated time
of incubation, cells were stained with 2 mg/ml of acridine Linearized pSV2gptMTLM or pSV2gpt was introduced
into the Jurkat cell line and mycophenolic acid-resistantorange and viewed immediately under a fluororescence
microscope. The percentage of viable versus apoptotic cells were obtained. Then the LMP1 transfectants or con-
trol cells were transferred to the medium containing 0.1%cells was determined from counts of at least 200 cells
per individual culture well with duplicate cultures. fetal calf serum (FCS) and the kinetics of apoptosis was
assayed by the method of acridine orange staining. AsFor analysis of the DNA laddering, cells were disrupted
in 10 mM Tris–HCl, pH 7.6, 0.15 M NaCl, 5 mM MgCl2 , shown in Fig. 1A, in control vector transfectant, the rapid
induction of apoptosis was observed and about 90% ofand 0.5% Triton X-100. After centrifugation at 1000 g,
the intact nuclei were pelleted. The nuclei were then cells were died by apoptosis at Day 6 after transfer to
medium containing 0.1% FCS. Similar results were ob-extracted in 10 mM Tris– HCl, pH 7.6, 0.4 M NaCl, 1 mM
EDTA, and 1% Triton-X 100 and centrifuged at 12,000 g to tained in the case of parental Jurkat cells (data not
shown). In contrast, the LMP1 transfectants showed re-separate the nucleoplasm. Nucleoplasm was incubated
with 20 mg/ml RNase for 1 hr at room temperature and sistance to apoptosis and more than 50% of the cells
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FIG. 2. Sensitivity to apoptosis of subclones of control and LMP1
transfectants of Jurkat cells. Percentage cell viability was assayed by
acridine orange staining after 3 and 5 days of culture in medium con-
taining 0.1% FCS.
branes. LMP1 protein was identified by hybridization with
murine monoclonal antibodies against LMP1 (CS1-4). As
shown in Fig. 3, LMP1 was expressed in all four clones
of LMP1 transfectants and the sizes of LMP1 in LMP1-
transfected clones were similar to those of endogenous
LMP1 in Raji cells.FIG. 1. Kinetics of cell survival in control and LMP1 transfectants of
It is well known that expression of LMP1 induces theJurkat cells. (A) Percentage of cell viability was assayed by acridine
orange staining daily for up to 6 days of culture in medium containing expression of the Bcl-2 oncogene and protects the EBV-
0.1% FCS. Closed symbols represent LMP1 transfectants (J-LMP) and negative B-cell lines from apoptosis (Tsujimoto, 1989;
open symbols represent control transfectants (J-gpt). (B) Gel electro- Henderson et al., 1991). Therefore, the effects of LMP1
phoresis of low molecular DNA extracted from control and LMP1
transfectants after 2–4 days of culture in either 6% FCS or 0.1% FCS.
Extracts were made from an equal number of cells in each case.
were viable even at Day 6 after transfer to low FCS me-
dium. Gel electrophoresis patterns of low molecular DNA
from LMP1 and control vector transfectants were com-
pared. As shown in Fig. 1B, control vector transfectants
showed the laddering of DNA characteristic for apoptosis
when cultured in 0.1% FCS medium for 4 days. DNA
laddering was also demonstrated in the LMP1 transfec-
tants, but at a much reduced level.
Next, LMP1 and vector transfectants were further sub-
cloned and the sensitivity to apoptosis of each clone was
studied. Cells were cultured in 0.1% FCS medium for 3
or 5 days and stained with acridine orange. As shown
in Fig. 2, individual clones of LMP1 transfectants also
showed resistance to apoptosis when compared with
the clones of vector transfectants or parental cells.
Expression of LMP1 and Bcl-2 in LMP1-transfected
clones
The expression of LMP1 in LMP1-transfected clones
was determined by immunoblot analysis. Protein from FIG. 3. Expression of LMP1 and Bcl-2 in subclones of control and
four LMP1-transfected clones was fractionated by 8% LMP1 transfectants of Jurkat cells. Protein extracts were immunoblotted
and probed with the monoclonal antibodies specific for LMP1 or Bcl-2.SDS –PAGE and transferred onto PVDF nylon mem-
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FIG. 4. Effects of CdCl2 on the expression of LMP1, Bcl-2, and Bax FIG. 5. Expression of c-Myc in control and LMP1-expressing sub-
in subclones of control and LMP1-expressing subclones of Jurkat cells. clones of Jurkat cells. Extracts from Jurkat cells or subclones of control
Control and LMP1-expressing clones (gpt 3 and LMP B-9, respectively) and LMP1 expressing clones were immunoblotted and probed with
were treated with CdCl2 at the concentrations of 2 mM for 16 hr or 10 monoclonal antibodies specific for c-Myc. The first lane, Jurkat (1:1),
mM for 8 hr. Protein extracts were immunoblotted and probed with indicates the result of 1:1 diluted cell extract from Jurkat cells (the
monoclonal antibodies specific for LMP1 or Bcl-2 or polyclonal antibod- second lane).
ies for Bax.
5, the expression of c-Myc protein was reduced in LMP1-
on Bcl-2 expression in each clone of LMP1 transfectants
expressing clones when compared with that of parental
were examined by immunoblot analysis. As shown in
Jurkat cells or vector-transfected clone gpt-1. The inten-
Fig. 3, vector-transfected Jurkat cells spontaneously ex-
sity of the c-Myc band in LMP1-expressing clones, B-3,
pressed Bcl-2. The level of Bcl-2 was not affected by the
B-5, and B-9, was similar to that of 1:1 diluted cell extract
expression of LMP1 in the clones of LMP1 transfectants.
from Jurkat cells. To confirm whether LMP1 down-regu-
These results indicate that LMP1 expression does not
lated the expression of c-Myc in Jurkat cells, the effects
up-regulate the expression of Bcl-2 in Jurkat cells. How-
of CdCl2 on the expression of c-Myc were examined. Byever, it cannot be excluded that the induced level of Bcl-
treatment of LMP B-9 clone with 2 mM CdCl2 for 24 hr2 is too low to be detected. To examine the possibility,
or 10 mM CdCl2 for 8 hr, the expression of LMP1 wasthe expression of Bcl-2 following induction of LMP1 by
enhanced (Fig. 4), whereas the expression of c-Myc was
CdCl2 was examined, as pSV2gptMTLM consisted of the extremely depressed (Fig. 6). The expression of c-Myc
human metallothionein promoter and capping site. As
in the control clone was not affected by the treatment
shown in Fig. 4, although the expression of LMP1 was
with CdCl2 . These results indicate that in Jurkat cells,drastically enhanced by the treatment of LMP1-trans-
LMP1 down-regulates the expression of c-Myc.
fected clone B-9 with CdCl2 , Bcl-2 remained at the same To determine the role of c-Myc in apoptosis induced
level as that in the untreated clone. Therefore, it is con-
cluded that LMP1 does not affect the expression of Bcl-
2 in the Jurkat cell line. These results indicate that in
Jurkat cells, the inhibitory effect of LMP1 on apoptosis
induced by serum deprivation is independent of deregu-
lation of Bcl-2. The expression of Bax also was not af-
fected by LMP1 in Jurkat cells.
Expression of c-Myc in LMP1-transfected clones
Recent evidence shows that deregulation of c-Myc in-
fluences suppression of apoptosis (Evan et al., 1992; Shi
et al., 1992; Cherney et al., 1994). To determine whether
deregulation of c-Myc was induced by LMP1, the level
of c-Myc protein in LMP1-expressing clones was deter-
FIG. 6. Effect of CdCl2 on expression of c-Myc in control and LMP1-mined by immunoblot analysis. Proteins extracted from
expressing subclones of Jurkat cells. Cell extracts from subclones gptpSV2gptMTLM- or pSV2gpt-transfected clones or paren-
3 and LMP B-9 treated with CdCl2 at concentrations of 2 mM for 16 hrtal Jurkat cells were fractionated by 10% SDS–PAGE. c- or 10 mM for 8 hr were the same as those described in Fig. 4. Protein
Myc protein was identified by hybridization with murine extracts were immunoblotted and probed with monoclonal antibodies
specific for c-Myc.monoclonal antibodies against c-Myc. As shown in Fig.
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induced by serum deprivation. It is concluded that the
effects studied here reflect a function of wild-type LMP1
for the following two reasons. It has been demonstrated
that a high level of the expression of wild-type LMP1 is
toxic to cells (Hammerschmidt et al., 1989). The promoter
of metallothionein gene used in our experiment is not so
strong as that of cytomegalovirus early gene. Therefore, it
can be considered that Jurkat cells can survive in normal
medium despite the expression of LMP1. LMP1 can be
overproduced by the treatment of LMP1-transfected
clones with 10 mM CdCl2 (Fig. 4). After 24-hr treatment
with 10 mM CdCl2 , LMP1-transfected cells were killed,
but vector-transfected cells were not affected (data not
shown). These results suggest that LMP1 gene in the
Jurkat derivatives is wild-type. Second, the LMP1 gene
in clone LMP B-9 (about 500 bp DNA from the first codon
which plays an important role in cytotoxicity, as demon-
strated by Hammerschmidt et al., 1989) was amplified
by PCR and sequenced. The sequence determined was
identical to that of wild-type LMP1 (data not shown).
Several reports have demonstrated that the expression
of LMP1 in EBV-positive B-cell lines results in the induc-
tion of the Bcl-2 oncogene and that the overexpression
of Bcl-2 confers a survival function upon the cells (Tsuji-FIG. 7. Effect of antisense and sense oligonucleotides to c-myc on
moto, 1989; Henderson et al., 1991). However, the levelcell viability and the expression of c-Myc protein. (A) Percentage cell
viability was assayed by acridine orange staining after 4 days of culture of Bcl-2 in LMP1-expressing clones of Jurkat cells was
in medium containing 0.1% FCS in the presence of 10 mM antisense similar to that of parental or vector-transfected cells. The
or sense oligonucleotides to c-myc. (B) Extracts from the cells cultured expression of LMP1 was drastically increased by the
in the presence of 10 mM antisense or sense oligonucleotides to c-myc
treatment of LMP1-transfected cells with CdCl2 , but thefor 1 day were immunoblotted and probed with monoclonal antibodies
levels of Bcl-2 did not correlate with the increase ofspecific for c-Myc.
LMP1. These results indicate that in the case of Jurkat
T cells, LMP1 does not up-regulate Bcl-2. Martin et al.by serum deprivation, antisense oligonucleotides di-
and Rowe et al. have also reported that the expressionrected to the translation start site of c-myc were added to
of LMP1 in human primary B cells, some lymphoblastoidJurkat cells. After 3 days incubation in medium containing
cells, and BALB/c3T3 cells does not correlate with the0.1% FCS, apoptotic cells were determined by acridine
expression of Bcl-2 (Martin et al., 1993; Rowe et al., 1994).orange staining. As shown in Fig. 7A, antisense oligonu-
Therefore, it is likely that the functions of LMP1 differcleotides to c-myc inhibited apoptosis induced by serum
among different cell types, although the molecular mech-deprivation, whereas sense oligonucleotides to c-myc
anisms of regulation of cellular genes by LMP1 remainhad no effect. In a separate experiment, similar results
to be clarified. It has been suggested that Bcl-2 exertswere obtained; the percentages of apoptotic cells were
its action through heterodimerizatin with Bax, which is57.5 and 26.2% in Jurkat cells cultured under serum depri-
a member of the Bcl-2 family (Yin et al., 1994). LMP1vation in the absence and the presence of 10 mM c-
expression did not affect the levels of Bax in Jurkat cells.myc antisense oligonucleotides, respectively (data not
These results suggest that LMP1 expression protectsshown). The ability of c-myc antisense oligonucleotides
Jurkat T cells from apoptosis induced by serum depriva-to inhibit cell death in Jurkat cells correlated with their
tion independent of the Bcl-2/Bax system.effects on c-Myc protein expression. Immunoblot analy-
Recently, it has been reported that the down-regulationsis with monoclonal antibodies against c-Myc revealed
of endogenous c-Myc inhibits apoptosis or that overex-a loss of c-Myc from cells cultured in the c-myc antisense
pression of c-Myc induces apoptosis (Evan et al., 1992;oligonucleotides (Fig. 7B). These results together sug-
Shi et al., 1992; Cherney et al., 1994). The levels of c-gest that LMP1 expression and subsequent down-regu-
Myc in LMP1-expressing clones of Jurkat cells were de-lation of c-Myc, in part, protect Jurkat cells from apoptosis
creased when compared with those in parental cells orinduced by serum deprivation.
vector-transfected clones. Down-regulation of c-Myc ex-
DISCUSSION pression by LMP1 in Jurkat cells was confirmed by using
LMP1-expressing clones treated with CdCl2 . The levelsThe present study shows that EBV LMP1-expressing
clones of Jurkat T cells acquires resistance to apoptosis of c-Myc protein decreased with the increase of LMP1
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and bcl-2 in Reed-Sternberg cells in Hodgkin’s disease. Histopathol-expression with treatment with CdCl2 . Suppression of c-
ogy 21, 72–73.Myc expression by LMP1 may be unique to Jurkat T
Balchwal, V. R., and Sugden, B. (1988). Transformation of Balb 3T3 cells
cells, because the level of c-Myc in the pSV2gptMTLM- by the BNLF1 gene of Epstein-Barr virus. Oncogene 2, 461–467.
transfected intestine epithelial cell line was not affected Bhagat, S. K. M., Medeiros, L. J., Weiss, L. M., Wang, J., Raffelt, M., and
Stetler-Stevenson, M. (1993). bcl-2 expression in Hodgkin’s disease:by the expression of LMP1 (data not shown). The present
Correlation with the t(14; 18) translocation and Epstein-Barr virus.study demonstrates that antisense oligonucleotides to c-
Am. J. Clin. Pathol. 99, 604–608.myc inhibit apoptosis in serum-depleted Jurkat T cells.
Chen, C., Sadler, R. H., Walling, D. M., Su, I., Hsieh, H., and Raab-Traub,
These results together suggest that in the case of Jurkat N. (1993). Epstein-Barr virus (EBV) gene expression in EBV-positive
T cells, down-regulation of c-Myc by LMP1 expression, peripheral T-cell lymphoma. J. Virol. 67, 6303–6308.
Cherney, B. W., Bhatia, K., and Tosato, G. (1994). A role for deregulatedin part, participates in protection of cells from apoptosis
c-Myc expression in apoptosis of Epstein-Barr virus-immortalized Binduced by serum deprivation. Recent reports have
cells. Proc. Natl. Acad. Sci. USA 91, 12967–12971.shown that LMP1 induces the expression of A20 with
Cleary, M. L., Dorfman, R. F., and Sklar, J. (1986). Failure in immunologi-
anti-apoptotic properties (Laherty et al., 1992; Sarma et cal control of the virus infection: Post-transplant lymphomas. In ‘‘The
al., 1995). Therefore, in addition to down-regulation of c- Epstein-Barr Virus: Recent Advances’’ (M. A. Epstein and B. C.
Achong, Eds.), pp. 163–181. Heinemann, London.Myc, induction of A20 also may play a role in resistance
Dowson, C. W., Rickinson, A. B., and Young, L. S. (1990). Epstein-Barrof LMP1-expressing Jurkat cells to apoptosis induced by
virus latent membrane protein inhibits human epithelial cell differen-serum deprivation.
tiation. Nature (London) 344, 777–780.
It has become apparent that EBV infection may occur Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks,
in a much wider range of cell types than was previously M., Waters, C. M., Penn, L. Z., and Hancock, D. C. (1992). Induction
of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128.realized and is associated with tumors derived from non-
Fa˚hraeus, R., LiFu, H., Ernberg, I., Finke, J., Rowe, M., Klein, G., Falk,B-cell origin (Klein, 1979; Cleary et al., 1986; Lenoir, 1986;
K., Nilsson, E., Yadav, M., Busson, P., Tursz, T., and Kallin, B. (1988).Young et al., 1989; Chen et al., 1993; Pellesen et al., 1993;
Expression of Epstein-Barr virus proteins in nasopharyngeal carci-
Khan and Coates, 1994). Among them, many cases of noma. Int. J. Cancer 42, 329–338.
NPC and Hodgkin’s disease express LMP1 but not Hammerschmidt, W., Sugden, B., and Baichwal, V. (1989). The trans-
forming domain alone of the latent membrane protein of Epstein-EBNA-2 (Fahraeus et al., 1988; Young et al., 1988; Li-Fu
Barr virus is toxic to cells when expressed at high levels. J. Virol.et al., 1991; Chen et al., 1993; Pallesen et al., 1993; Khan
63, 2467–2475.and Coates, 1994). However, the pathogenic role of LMP1
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Long-
in such tumors remains to be clarified. LMP1 is known necker, R., Kieff, E., and Rickinson, A. (1991). Induction of bcl-2 ex-
to inhibit the differentiation of human epithelial cells and pression by Epstein-Barr virus latent membrane protein 1 protects
infected B cells from programmed cell death. Cell. 65, 1107–1115.to induce the expression of various cellular activation
Kawanishi, M., Sugawara, K., Ito, Y. (1981). Epstein-Barr virus-inducedand adhesion molecules (Dowson et al., 1990; Wang et
polypeptides: A comparative study with superinfected Raji, IUdR-al., 1988, 1990; Rowe et al., 1994). Miller et al. have shown
treated, and n-butyrate-treated P3HR-1 cells. Virology 109, 72–81.
that LMP1 induces expression of the epidermal growth Kawanishi, M. (1993). Epstein-Barr virus induces fragmentation of chro-
factor receptor (Miller et al., 1995). In addition to such mosomal DNA during lytic infection. J. Virol. 67, 7654–7658.
Khan, G., and Coates, P. J. (1994). The role of Epstein-Barr virus in thebiological activities, anti-apoptotic function of LMP1 is
pathogenesis of Hodgkin’s disease. J. Pathol. 174, 141–149.likely to contribute to pathogenesis of NPC and Hodgkin’s
Khan, G., Gupta, R. K., Coates, P. J., and Slavin, G. (1993). Epstein-disease, because the deregulation of apoptosis may be
Barr virus infection and bcl-2 proto-oncogene expression: Separate
of general significance in the process of multistep carci- events in the pathogenesis of Hodgkin’s disease? Am. J. Pathol. 143,
nogenesis. The recent studies have shown that although 1270–1274.
Bcl-2 is expressed in Hodgkin and Read-Sternberg (HRS) Kieff, E., and Liebowitz, D. (1989). The Epstein-Barr virus. In ‘‘Virology’’
(B. Fields and D. Knipe, Eds.), pp. 1889–1920. Raven Press, Newcells, the malignant population of Hodgkin’s disease, and
York.undifferentiated NPC, its expression is not correlated
Klein, G. (1979). The relationship of the virus to nasopharyngeal carci-with LMP1 (Armstrong et al., 1992; Bhagat et al., 1993; noma. In ‘‘The Epstein-Barr Virus’’ (M. A. Epstein and B. Achong,
Khan et al., 1993). The present findings propose the pos- Eds.), pp. 340–350. Springer-Verlag, Berlin.
sibility that LMP1 possesses the ability to override Laherty, C. D., Hu, H. M., Opipai, A. W., Wang, F., and Dixit, V. M. (1992).
The Epstein-Barr virus LMP1 gene product induces A20 zinc fingerapoptosis of non-B-cell origin without up-regulation of
protein expression by activating nuclear factor kB. J. Biol. Chem. 267,Bcl-2. Further studies on LMP1 expression and subse-
24157–24160.quent regulation of apoptosis in various cell types will
Lenoir, G. M. (1986). Role of the virus, chromosomal translocations and
be required for clarifying the role of LMP1 in the patho- cellular oncogenes in the aetiology of Burkitt’s lymphoma. In ‘‘The
genesis of EBV malignancy. Epstein-Barr Virus: Recent Advances’’ (M. A. Epstein and B. C.
Achong, Eds.), pp. 183–205. Heinemann, London.
ACKNOWLEDGMENT Li-Fu, H., Minarovits, J., Shi-Long, C., Contreras-Salazar, B., Rymo, L.,
The author thanks Dr. Elliott Kieff for pSV2gptMTLM. Falk, K., Klein, G., and Ernberg, I. (1991). Variable expression of laten
membrane protein in nasopharyngeal carcinoma can be related to
REFERENCES methylatin status of the Epstein-Barr virus BNLF-1 5*-flanking region.
J. Virol. 65, 1558–1567.Armstrong, A. A., Gallagher, A., Krajewski, A. S. et al. (1992). The expres-
sion of the EBV latent membrane (LMP1) is independent of CD23 Martin, J. M., Veis, D., Korsmeyer, S. J., and Sugden, B. (1993). Latent
AID VY 8370 / 6a28$$$362 01-21-97 00:21:10 vira AP: Virology
250 MICHIKO KAWANISHI
membrane protein of Epstein-Barr virus induces cellular phenotypes Wang, D., Liebowitz, D., and Kieff, E. (1985). An EBV membrane protein
independently of expression of Bcl-2. J. Virol. 67, 5269–5278. expressed in immortalized lymphocytes transforms established ro-
Miller, W. E., Earp, H. S., and Raab-Traub, N. (1995). The Epstein-Barr dent cells. Cell 43, 831–840.
virus latent membrane protein 1 induces expression of the epidermal Wang, D., Liebowitz, D., Wang, F., Gregory, C., Rickinson, A., Larson,
growth factor receptor. J. Virol. 69, 4390–4398. R., Springer, T., and Kieff, E. (1988). Epstein-Barr virus latent infection
Pallesen, G., Hamilton-Dutoit, S. J., and Zhou, X. (1993). The association membrane protein alters the human B-lymphocyte phenotype: Dele-
of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodg- tion of the amino terminus abolishes activity. J. Virol. 62, 4173–4184.
kin’s disease: Two new developments in the EBV field. Adv. Cancer Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R.,
Res. 62, 179–239. Rickinson, A., and Kieff, E. (1990). Epstein-Barr virus latent membrane
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., protein (LMP1) and nuclear proteins 2 and 3C are effecters of pheno-
Lundgren, E., and Rickinson, A. B. (1994). Upregulation of bcl-2 by the typic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively
Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific induce CD23. J. Virol. 64, 2309–2318.
response that is delayed relative to NF-kB activation and to induction
Yin, X-M., Oltvai, Z. N., and Korsmeryer, S. J. (1994). BH1 and BH2 do-
of cell surface markers. J. Virol. 68, 5602–5612.
mains of Bcl-2 are required for inhibition of apoptosis and heterodim-
Sarma, V., Lin, Z., Clark, L., Rust, B. M., Tewari, M., Noelle, R. J., and
erization with Bax. Nature 369, 321–323.Dixit, V. M. (1995). Activation of the B-cell surface receptor CD40
Young, L., Dawson, C., Clark, D., Rupani, H., Busson, P., Tursz, T.,induces A20, a novel Zinc finger protein that inhibits apoptosis. J.
Johnson, A., and Rickinson, A. B. (1988). Epstein-Barr virus gene ex-Biol. Chem. 270, 12343–12346.
pression in nasopharyngeal carcinoma. J. Gen. Virol. 69, 1051–1065.Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., Green,
Young, L., Alfieri, C., Hennessy, K., Evans, H., O’Hara, C., Anderson,D. R. (1992). Role for c-myc in activation-induced apoptotic cell death
K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., and Cohen, J. I.in T cell hybridomas. Science 257, 212–214.
(1989). Epstein-Barr virus transformation associated genes are ex-Tsujimoto, Y. (1989). Overexpression of the human BCL-2 gene protect
pressed in tissues from patients with EBV lymphoproliferative dis-results in growth enhancement of Epstein-Barr virus-immortalized B
cells. Proc. Natl. Acad. Sci. USA 86, 1958–1962. ease. N. Engl. J. Med. 321, 1080–1085.
AID VY 8370 / 6a28$$$363 01-21-97 00:21:10 vira AP: Virology
